Palantir stock is on a wild hot streak. Here's why so few analysts are bullish.
Palantir stock is trading at a lofty valuation "which history suggests is nearly impossible to grow into," Deutsche Bank's ...
Swiss Regulator Finma Leans Against UBS Plea on Competitiveness
The chief executive of Switzerland’s financial regulator signaled that he’s resisting pressure to accept the competitiveness ...
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation ...
KKR Capital Markets Unit Reports Record $1 Billion of Fees
KKR & Co.’s business of arranging financing for its portfolio companies and other firms reported record annual fees last year ...